Skip to main content
Top
Published in: Abdominal Radiology 3/2005

01-06-2005 | Invited update

MR and optical approaches to molecular imaging

Authors: T. Persigehl, W. Heindel, C. Bremer

Published in: Abdominal Radiology | Issue 3/2005

Login to get access

Abstract

With an increasing understanding of the molecular basis of disease, various new imaging targets have recently been defined that potentially allow for an early, sensitive, and specific diagnosis of disease or monitoring of treatment response. Different approaches to depict these molecular structures in vivo are currently being explored by the molecular imaging community. We briefly review methodologies for molecular imaging by magnetic resonance imaging and optical methods. Special emphasis is put on different contrast agent designs (e.g., targeted and smart probes). New technical developments in optical imaging are briefly discussed. In addition, current research results are put into a clinical perspective to elucidate the potential merits one might expect from this new research field.
Literature
1.
go back to reference Weissleder, R, Mahmood, U 2001Molecular imagingRadiology219316333PubMed Weissleder, R, Mahmood, U 2001Molecular imagingRadiology219316333PubMed
2.
go back to reference Bremer, C, Ntziachristos, V, Weissleder, R 2003Optical-based molecular imaging: contrast agents and potential medical applicationsEur Radiol13231243PubMed Bremer, C, Ntziachristos, V, Weissleder, R 2003Optical-based molecular imaging: contrast agents and potential medical applicationsEur Radiol13231243PubMed
3.
go back to reference Brasch, RC, Li, KC, Husband, JE, et al. 2000In vivo monitoring of tumor angiogenesis with MR imagingAcad Radiol7812823PubMed Brasch, RC, Li, KC, Husband, JE,  et al. 2000In vivo monitoring of tumor angiogenesis with MR imagingAcad Radiol7812823PubMed
4.
go back to reference Bremer, C, Mustafa, M, Bogdanov, A,Jr, et al. 2003Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in miceRadiology226214220PubMed Bremer, C, Mustafa, M, Bogdanov, A,Jr,  et al. 2003Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in miceRadiology226214220PubMed
5.
go back to reference Johnson, GA, Benveniste, H, Black, RD, et al. 1993Histology by magnetic resonance microscopyMagn Reson Q9130PubMed Johnson, GA, Benveniste, H, Black, RD,  et al. 1993Histology by magnetic resonance microscopyMagn Reson Q9130PubMed
6.
go back to reference Smith, BR, Johnson, GA, Groman, EV, Linney, E 1994Magnetic resonance microscopy of mouse embryosProc Natl Acad Sci USA9135303533PubMed Smith, BR, Johnson, GA, Groman, EV, Linney, E 1994Magnetic resonance microscopy of mouse embryosProc Natl Acad Sci USA9135303533PubMed
7.
go back to reference Bogdanov, A, Matuszewski, L, Bremer, C, et al. 2002Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecular targetsMol Imaging11623CrossRefPubMed Bogdanov, A, Matuszewski, L, Bremer, C,  et al. 2002Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecular targetsMol Imaging11623CrossRefPubMed
8.
go back to reference Wickline, SA, Lanza, GM 2002Molecular imaging, targeted therapeutics, and nanoscienceJ Cell Biochem399097CrossRef Wickline, SA, Lanza, GM 2002Molecular imaging, targeted therapeutics, and nanoscienceJ Cell Biochem399097CrossRef
9.
go back to reference Lanza, GM, Yu, X, Winter, PM, et al. 2002Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosisCirculation10628422847CrossRefPubMed Lanza, GM, Yu, X, Winter, PM,  et al. 2002Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosisCirculation10628422847CrossRefPubMed
10.
go back to reference Brasch, RC, Gossmann, A, Helbich, TH, et al. 2002Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition? Acad Radiol2S326S327CrossRef Brasch, RC, Gossmann, A, Helbich, TH,  et al. 2002Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition? Acad Radiol2S326S327CrossRef
11.
go back to reference Daldrup, H, Shames, DM, Wendland, M, et al. 1998Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast mediaAJR171941949PubMed Daldrup, H, Shames, DM, Wendland, M,  et al. 1998Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast mediaAJR171941949PubMed
12.
go back to reference Brasch, R, Turetschek, K 2000MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status reportEur J Radiol34148155CrossRefPubMed Brasch, R, Turetschek, K 2000MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status reportEur J Radiol34148155CrossRefPubMed
13.
go back to reference Brasch, RC, Daldrup, H, Shames, D, et al. 1998Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor gradeAcad Radiol1S2S5 Brasch, RC, Daldrup, H, Shames, D,  et al. 1998Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor gradeAcad Radiol1S2S5
14.
go back to reference Turetschek, K, Huber, S, Floyd, E, et al. 2001MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlationRadiology218562569PubMed Turetschek, K, Huber, S, Floyd, E,  et al. 2001MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlationRadiology218562569PubMed
15.
go back to reference Helbich, TH, Roberts, TP, Rollins, MD, et al. 2002Noninvasive assessment of wound-healing angiogenesis with contrast-enhanced MRIAcad Radiol1 S145S147CrossRef Helbich, TH, Roberts, TP, Rollins, MD,  et al. 2002Noninvasive assessment of wound-healing angiogenesis with contrast-enhanced MRIAcad Radiol1 S145S147CrossRef
16.
go back to reference Roberts, TP, Turetschek, K, Preda, A, et al. 2002Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weightsAcad Radiol2S511S513CrossRef Roberts, TP, Turetschek, K, Preda, A,  et al. 2002Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weightsAcad Radiol2S511S513CrossRef
17.
go back to reference Turetschek, K, Preda, A, Floyd, E, et al. 2002MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer modelAcad Radiol2S519S520CrossRef Turetschek, K, Preda, A, Floyd, E,  et al. 2002MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer modelAcad Radiol2S519S520CrossRef
18.
go back to reference Turetschek, K, Preda, A, Floyd, E, et al. 2003MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer modelEur J Nucl Med Mol Imaging30448455PubMed Turetschek, K, Preda, A, Floyd, E,  et al. 2003MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer modelEur J Nucl Med Mol Imaging30448455PubMed
19.
go back to reference Daldrup-Link, HE, Brasch, RC 2003Macromolecular contrast agents for MR mammography: current statusEur Radiol13354365PubMed Daldrup-Link, HE, Brasch, RC 2003Macromolecular contrast agents for MR mammography: current statusEur Radiol13354365PubMed
20.
go back to reference Padhani, AR 2002Dynamic contrast-enhanced MRI in clinical oncology: current status and future directionsJ Magn Reson Imaging16407422 Padhani, AR 2002Dynamic contrast-enhanced MRI in clinical oncology: current status and future directionsJ Magn Reson Imaging16407422
21.
go back to reference Padhani, AR, Neeman, M 2001Challenges for imaging angiogenesisBr J Radiol74886890PubMed Padhani, AR, Neeman, M 2001Challenges for imaging angiogenesisBr J Radiol74886890PubMed
22.
go back to reference Schellenberger, EA, Bogdanov, A,Jr, Hogemann, D, et al. 2002Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRIMol Imaging1102107CrossRefPubMed Schellenberger, EA, Bogdanov, A,Jr, Hogemann, D,  et al. 2002Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRIMol Imaging1102107CrossRefPubMed
23.
go back to reference Kang, HW, Josephson, L, Petrovsky, A, et al. 2002Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell cultureBioconjug Chem13122127CrossRefPubMed Kang, HW, Josephson, L, Petrovsky, A,  et al. 2002Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell cultureBioconjug Chem13122127CrossRefPubMed
24.
go back to reference Flacke, S, Fischer, S, Scott, MJ, et al. 2001Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaquesCirculation10412801285PubMed Flacke, S, Fischer, S, Scott, MJ,  et al. 2001Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaquesCirculation10412801285PubMed
25.
go back to reference Winter, PM, Caruthers, SD, Kassner, A, et al. 2003Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imagingCancer Res6358385843PubMed Winter, PM, Caruthers, SD, Kassner, A,  et al. 2003Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imagingCancer Res6358385843PubMed
26.
go back to reference Lanza, GM, Abendschein, DR, Yu, X, et al. 2002Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technologyAcad Radiol2 S330S331CrossRef Lanza, GM, Abendschein, DR, Yu, X,  et al. 2002Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technologyAcad Radiol2 S330S331CrossRef
27.
go back to reference Winter, PM, Caruthers, SD, Yu, X, et al. 2003Improved molecular imaging contrast agent for detection of human thrombusMagn Reson Med50411416CrossRefPubMed Winter, PM, Caruthers, SD, Yu, X,  et al. 2003Improved molecular imaging contrast agent for detection of human thrombusMagn Reson Med50411416CrossRefPubMed
28.
go back to reference Winter, PM, Morawski, AM, Caruthers, SD, et al. 2003Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticlesCirculation10822702274CrossRefPubMed Winter, PM, Morawski, AM, Caruthers, SD,  et al. 2003Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticlesCirculation10822702274CrossRefPubMed
29.
go back to reference Sipkins, DA, Cheresh, DA, Kazemi, MR, et al. 1998Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imagingNat Med4623626CrossRefPubMed Sipkins, DA, Cheresh, DA, Kazemi, MR,  et al. 1998Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imagingNat Med4623626CrossRefPubMed
30.
go back to reference Artemov, D, Mori, N, Ravi, R, Bhujwalla, ZM 2003Magnetic resonance molecular imaging of the HER-2/neu receptorCancer Res6327232727PubMed Artemov, D, Mori, N, Ravi, R, Bhujwalla, ZM 2003Magnetic resonance molecular imaging of the HER-2/neu receptorCancer Res6327232727PubMed
31.
go back to reference Artemov, D, Mori, N, Okollie, B, Bhujwalla, ZM 2003MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticlesMagn Reson Med49403408CrossRefPubMed Artemov, D, Mori, N, Okollie, B, Bhujwalla, ZM 2003MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticlesMagn Reson Med49403408CrossRefPubMed
32.
go back to reference Louie, AY, Huber, MM, Ahrens, ET, et al. 2000In vivo visualization of gene expression using magnetic resonance imagingNat Biotechnol18321325CrossRefPubMed Louie, AY, Huber, MM, Ahrens, ET,  et al. 2000In vivo visualization of gene expression using magnetic resonance imagingNat Biotechnol18321325CrossRefPubMed
33.
go back to reference Josephson, PJ, Weissleder, R 2001Magnetic nanosensors for the detection of oligonucleotide sequencesAngew Chem In Ed4032043206CrossRef Josephson, PJ, Weissleder, R 2001Magnetic nanosensors for the detection of oligonucleotide sequencesAngew Chem In Ed4032043206CrossRef
34.
go back to reference Perez, JM, Josephson, L, O’Loughlin, T, et al. 2002Magnetic relaxation switches capable of sensing molecular interactionsNat Biotechnol20816820PubMed Perez, JM, Josephson, L, O’Loughlin, T,  et al. 2002Magnetic relaxation switches capable of sensing molecular interactionsNat Biotechnol20816820PubMed
35.
go back to reference Perez, JM, O’Loughin, T, Simeone, FJ, et al. 2002DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agentsJ Am Chem Soc12428562857CrossRefPubMed Perez, JM, O’Loughin, T, Simeone, FJ,  et al. 2002DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agentsJ Am Chem Soc12428562857CrossRefPubMed
36.
go back to reference Grimm, J, Perez, JM, Josephson, L, Weissleder, R 2004Novel nanosensors for rapid analysis of telomerase activityCancer Res64639643PubMed Grimm, J, Perez, JM, Josephson, L, Weissleder, R 2004Novel nanosensors for rapid analysis of telomerase activityCancer Res64639643PubMed
37.
go back to reference Kircher, MF, Allport, JR, Graves, EE, et al. 2003In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumorsCancer Res6368386846PubMed Kircher, MF, Allport, JR, Graves, EE,  et al. 2003In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumorsCancer Res6368386846PubMed
38.
go back to reference Moore, A, Sun, PZ, Cory, D, et al. 2002MRI of insulitis in autoimmune diabetesMagn Reson Med47751758CrossRefPubMed Moore, A, Sun, PZ, Cory, D,  et al. 2002MRI of insulitis in autoimmune diabetesMagn Reson Med47751758CrossRefPubMed
39.
go back to reference Beckmann, N, Cannet, C, Fringeli-Tanner, M, et al. 2003Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantationMagn Reson Med49459467CrossRefPubMed Beckmann, N, Cannet, C, Fringeli-Tanner, M,  et al. 2003Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantationMagn Reson Med49459467CrossRefPubMed
40.
go back to reference Beckmann, N, Falk, R, Zurbrugg, S, et al. 2003Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritisMagn Reson Med4910471055CrossRefPubMed Beckmann, N, Falk, R, Zurbrugg, S,  et al. 2003Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritisMagn Reson Med4910471055CrossRefPubMed
41.
go back to reference Daldrup-Link, HE, Rudelius, M, Oostendorp, RA, et al. 2003Targeting of hematopoietic progenitor cells with MR contrast agentsRadiology228760767PubMed Daldrup-Link, HE, Rudelius, M, Oostendorp, RA,  et al. 2003Targeting of hematopoietic progenitor cells with MR contrast agentsRadiology228760767PubMed
42.
go back to reference Bulte, JW, Douglas, T, Witwer, B, et al. 2002Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agentsAcad Radiol2S332S335CrossRef Bulte, JW, Douglas, T, Witwer, B,  et al. 2002Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agentsAcad Radiol2S332S335CrossRef
43.
go back to reference Lewin, M, Carlesso, N, Tung, CH, et al. 2000Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNat Biotechnol18410414CrossRefPubMed Lewin, M, Carlesso, N, Tung, CH,  et al. 2000Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNat Biotechnol18410414CrossRefPubMed
44.
go back to reference Hill, JM, Dick, AJ, Raman, VK, et al. 2003Serial cardiac magnetic resonance imaging of injected mesenchymal stem cellsCirculation10810091014CrossRefPubMed Hill, JM, Dick, AJ, Raman, VK,  et al. 2003Serial cardiac magnetic resonance imaging of injected mesenchymal stem cellsCirculation10810091014CrossRefPubMed
45.
go back to reference Bulte, JW, Duncan, ID, Frank, JA 2002In vivo magnetic resonance tracking of magnetically labeled cells after transplantationJ Cereb Blood Flow Metab22899907CrossRefPubMed Bulte, JW, Duncan, ID, Frank, JA 2002In vivo magnetic resonance tracking of magnetically labeled cells after transplantationJ Cereb Blood Flow Metab22899907CrossRefPubMed
46.
go back to reference Bulte, JW, Zhang, S, Gelderen, P, et al. 1999Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelinationProc Natl Acad Sci USA961525615261CrossRefPubMed Bulte, JW, Zhang, S, Gelderen, P,  et al. 1999Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelinationProc Natl Acad Sci USA961525615261CrossRefPubMed
47.
go back to reference Ntziachristos, V, Tung, CH, Bremer, C, Weissleder, R 2002Fluorescence molecular tomography resolves protease activity in vivoNat Med8756760CrossRef Ntziachristos, V, Tung, CH, Bremer, C, Weissleder, R 2002Fluorescence molecular tomography resolves protease activity in vivoNat Med8756760CrossRef
48.
go back to reference Ntziachristos, V, Bremer, C, Graves, EE, Ripoll, J, Weissleder, R 2002In vivo tomographic imaging of near-infrared fluorescent probesMol Imaging18288CrossRefPubMed Ntziachristos, V, Bremer, C, Graves, EE, Ripoll, J, Weissleder, R 2002In vivo tomographic imaging of near-infrared fluorescent probesMol Imaging18288CrossRefPubMed
49.
go back to reference Ntziachristos, V, Bremer, C, Weissleder, R 2003Fluorescence imaging with near-infrared light: new technological advances that enable in-vivo molecular imagingEur Radiol13195208PubMed Ntziachristos, V, Bremer, C, Weissleder, R 2003Fluorescence imaging with near-infrared light: new technological advances that enable in-vivo molecular imagingEur Radiol13195208PubMed
50.
go back to reference Nztiachristos, V, Tung, C, Bremer, C, Weissleder, R 2001Fluorescence-mediated tomography resolves protease activity in vivoNat Med8757760CrossRef Nztiachristos, V, Tung, C, Bremer, C, Weissleder, R 2001Fluorescence-mediated tomography resolves protease activity in vivoNat Med8757760CrossRef
51.
go back to reference Ntziachristos, V, Yodh, AG, Schnall, M, Chance, B 2000Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancementProc Natl Acad Sci USA9727672772CrossRefPubMed Ntziachristos, V, Yodh, AG, Schnall, M, Chance, B 2000Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancementProc Natl Acad Sci USA9727672772CrossRefPubMed
52.
53.
go back to reference Gao, X, Chan, WC, Nie, S 2002Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encodingJ Biomed Opt7532537CrossRefPubMed Gao, X, Chan, WC, Nie, S 2002Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encodingJ Biomed Opt7532537CrossRefPubMed
54.
go back to reference Kim, S, Lim, YT, Soltesz, EG, et al. 2004Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNat Biotechnol229397CrossRefPubMed Kim, S, Lim, YT, Soltesz, EG,  et al. 2004Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNat Biotechnol229397CrossRefPubMed
55.
go back to reference Lim, YT, Kim, S, Nakayama, A, et al. 2003Selection of quantum dot wavelengths for biomedical assays and imagingMol Imaging25064CrossRefPubMed Lim, YT, Kim, S, Nakayama, A,  et al. 2003Selection of quantum dot wavelengths for biomedical assays and imagingMol Imaging25064CrossRefPubMed
56.
go back to reference Intes, X, Ripoll, J, Chen, Y, et al. 2003In vivo continuous-wave optical breast imaging enhanced with Indocyanine GreenMed Phys3010391047CrossRefPubMed Intes, X, Ripoll, J, Chen, Y,  et al. 2003In vivo continuous-wave optical breast imaging enhanced with Indocyanine GreenMed Phys3010391047CrossRefPubMed
57.
go back to reference Perlitz, CLK, Hauff, P, Wisniewski, S, Schirner, M 2002Molecular imaging of tumors using fluorescent dyes [abstract]Mol Imaging1184 Perlitz, CLK, Hauff, P, Wisniewski, S, Schirner, M 2002Molecular imaging of tumors using fluorescent dyes [abstract]Mol Imaging1184
58.
go back to reference Achilefu, S, Jimenez, HN, Dorshow, RB, et al. 2002Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agentsJ Med Chem4520032015CrossRefPubMed Achilefu, S, Jimenez, HN, Dorshow, RB,  et al. 2002Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agentsJ Med Chem4520032015CrossRefPubMed
59.
go back to reference Becker, A, Hessenius, C, Licha, K, et al. 2001Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligandsNat Biotechnol9327331CrossRef Becker, A, Hessenius, C, Licha, K,  et al. 2001Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligandsNat Biotechnol9327331CrossRef
60.
go back to reference Becker, A, Hessenius, C, Bhargava, S, et al. 2000Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumorsAnn NY Acad Sci921275278PubMed Becker, A, Hessenius, C, Bhargava, S,  et al. 2000Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumorsAnn NY Acad Sci921275278PubMed
61.
go back to reference Moon, LY, O’Loughlin, T, Tang, Y, et al. 2003Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugateBioconjug Chem14539545CrossRefPubMed Moon, LY, O’Loughlin, T, Tang, Y,  et al. 2003Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugateBioconjug Chem14539545CrossRefPubMed
62.
go back to reference Schellenberger, EA, Bogdanov, A,Jr, Petrovsky, A, et al. 2003Optical imaging of apoptosis as a biomarker of tumor response to chemotherapyNeoplasia5187192PubMed Schellenberger, EA, Bogdanov, A,Jr, Petrovsky, A,  et al. 2003Optical imaging of apoptosis as a biomarker of tumor response to chemotherapyNeoplasia5187192PubMed
63.
go back to reference Kang, HW, Weissleder, R, Bogdanov, A,Jr 2002Targeting of MPEG-protected polyamino acid carrier to human E-selectin in vitroAmino Acids23301308CrossRefPubMed Kang, HW, Weissleder, R, Bogdanov, A,Jr 2002Targeting of MPEG-protected polyamino acid carrier to human E-selectin in vitroAmino Acids23301308CrossRefPubMed
64.
go back to reference Zaheer, A, Lenkinski, RE, Mahmood, A, et al. 2001In vivo near-infrared fluorescence imaging of osteoblastic activityNat Biotechnol1911481154CrossRefPubMed Zaheer, A, Lenkinski, RE, Mahmood, A,  et al. 2001In vivo near-infrared fluorescence imaging of osteoblastic activityNat Biotechnol1911481154CrossRefPubMed
65.
go back to reference Ke, S, Wen, X, Gurfinkel, M, et al. 2003Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenograftsCancer Res6378707875PubMed Ke, S, Wen, X, Gurfinkel, M,  et al. 2003Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenograftsCancer Res6378707875PubMed
66.
go back to reference Weissleder, R, Tung, CH, Mahmood, U, Bogdanov, A,Jr 1999In vivo imaging of tumors with protease-activated near-infrared fluorescent probesNat Biotechnol17375378CrossRefPubMed Weissleder, R, Tung, CH, Mahmood, U, Bogdanov, A,Jr 1999In vivo imaging of tumors with protease-activated near-infrared fluorescent probesNat Biotechnol17375378CrossRefPubMed
67.
go back to reference Bremer, C, Bredow, S, Mahmood, U, et al. 2001Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse modelRadiology221523529PubMed Bremer, C, Bredow, S, Mahmood, U,  et al. 2001Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse modelRadiology221523529PubMed
68.
go back to reference Bremer, C, Tung, CH, Weissleder, R 2001In vivo molecular target assessment of matrix metalloproteinase inhibitionNat Med7743748CrossRefPubMed Bremer, C, Tung, CH, Weissleder, R 2001In vivo molecular target assessment of matrix metalloproteinase inhibitionNat Med7743748CrossRefPubMed
69.
go back to reference Marten, K, Bremer, C, Khazaie, K, et al. 2002Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in miceGastroenterology122406414PubMed Marten, K, Bremer, C, Khazaie, K,  et al. 2002Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in miceGastroenterology122406414PubMed
70.
go back to reference Bremer, C, Tung, C-H, Bogdanov, A, Weissleder, R 2002Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypesRadiology222814818PubMed Bremer, C, Tung, C-H, Bogdanov, A, Weissleder, R 2002Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypesRadiology222814818PubMed
71.
go back to reference Weissleder, R, Moore, A, Mahmood, U, et al. 2000In vivo magnetic resonance imaging of transgene expressionNat Med6351355CrossRefPubMed Weissleder, R, Moore, A, Mahmood, U,  et al. 2000In vivo magnetic resonance imaging of transgene expressionNat Med6351355CrossRefPubMed
72.
go back to reference Weissleder, R 1999Molecular imaging: exploring the next frontierRadiology212609614PubMed Weissleder, R 1999Molecular imaging: exploring the next frontierRadiology212609614PubMed
73.
go back to reference Day, RN, Periasamy, A, Schaufele, F 2001Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleusMethods25418CrossRefPubMed Day, RN, Periasamy, A, Schaufele, F 2001Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleusMethods25418CrossRefPubMed
74.
go back to reference Chalfie, M, Tu, Y, Euskirchen, G, et al. 1994Green fluorescent protein as a marker for gene expressionScience263802805PubMed Chalfie, M, Tu, Y, Euskirchen, G,  et al. 1994Green fluorescent protein as a marker for gene expressionScience263802805PubMed
75.
go back to reference Yang, M, Baranov, E, Jiang, P, et al. 2000Whole-body optical imaging of green fluorescent protein-expressing tumors and metastasesProc Natl Acad Sci USA9712061211CrossRefPubMed Yang, M, Baranov, E, Jiang, P,  et al. 2000Whole-body optical imaging of green fluorescent protein-expressing tumors and metastasesProc Natl Acad Sci USA9712061211CrossRefPubMed
76.
go back to reference Moore, A, Marecos, E, Simonova, M, et al. 1998Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesisMicrovasc Res56145153CrossRefPubMed Moore, A, Marecos, E, Simonova, M,  et al. 1998Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesisMicrovasc Res56145153CrossRefPubMed
77.
go back to reference Moore, A, Sergeyev, N, Bredow, S, Weissleder, R 1998A model system to quantitate tumor burden in locoregional lymph nodes during cancer spreadInvasion Metastasis18192197CrossRefPubMed Moore, A, Sergeyev, N, Bredow, S, Weissleder, R 1998A model system to quantitate tumor burden in locoregional lymph nodes during cancer spreadInvasion Metastasis18192197CrossRefPubMed
78.
go back to reference Wang, W, Wyckoff, JB, Frohlich, VC, et al. 2002Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profilingCancer Res6262786288 Wang, W, Wyckoff, JB, Frohlich, VC,  et al. 2002Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profilingCancer Res6262786288
79.
80.
go back to reference Bhaumik, S, Gambhir, SS 2002Optical imaging of Renilla luciferase reporter gene expression in living miceProc Natl Acad Sci USA99377382CrossRefPubMed Bhaumik, S, Gambhir, SS 2002Optical imaging of Renilla luciferase reporter gene expression in living miceProc Natl Acad Sci USA99377382CrossRefPubMed
81.
go back to reference Funovics, MA, Alencar, H, Su, HS, et al. 2003Miniaturized multichannel near infrared endoscope for mouse imagingMol Imaging2350357CrossRefPubMed Funovics, MA, Alencar, H, Su, HS,  et al. 2003Miniaturized multichannel near infrared endoscope for mouse imagingMol Imaging2350357CrossRefPubMed
82.
go back to reference Josephson, L, Kircher, MF, Mahmood, U, et al. 2002Near-infrared fluorescent nanoparticles as combined MR/optical imaging probesBioconjug Chem13554560CrossRefPubMed Josephson, L, Kircher, MF, Mahmood, U,  et al. 2002Near-infrared fluorescent nanoparticles as combined MR/optical imaging probesBioconjug Chem13554560CrossRefPubMed
83.
go back to reference Kircher, MF, Mahmood, U, King, RS, et al. 2003A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineationCancer Res6381228125PubMed Kircher, MF, Mahmood, U, King, RS,  et al. 2003A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineationCancer Res6381228125PubMed
84.
go back to reference Harisinghani, MG, Barentsz, J, Hahn, PF, et al. 2003Noninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med34824912499PubMed Harisinghani, MG, Barentsz, J, Hahn, PF,  et al. 2003Noninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med34824912499PubMed
85.
go back to reference Mahmood, U, Tung, CH, Tang, Y, Weissleder, R 2002Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in miceRadiology224446451PubMed Mahmood, U, Tung, CH, Tang, Y, Weissleder, R 2002Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in miceRadiology224446451PubMed
86.
go back to reference Fang, J, Shing, Y, Wiederschain, D, et al. 2000Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelProc Natl Acad Sci USA9738843889PubMed Fang, J, Shing, Y, Wiederschain, D,  et al. 2000Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelProc Natl Acad Sci USA9738843889PubMed
88.
89.
go back to reference Aparicio, T, Kermorgant, S, Dessirier, V, et al. 1999Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in ratsCarcinogenesis2014451451CrossRefPubMed Aparicio, T, Kermorgant, S, Dessirier, V,  et al. 1999Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in ratsCarcinogenesis2014451451CrossRefPubMed
90.
go back to reference Herszenyi, L, Plebani, M, Carraro, P, et al. 1999The role of cysteine and serine proteases in colorectal carcinomaCancer8611351142CrossRefPubMed Herszenyi, L, Plebani, M, Carraro, P,  et al. 1999The role of cysteine and serine proteases in colorectal carcinomaCancer8611351142CrossRefPubMed
91.
go back to reference Koblinski, JE, Ahram, M, Sloane, BF 2000Unraveling the role of proteases in cancerClin Chim Acta291113135CrossRefPubMed Koblinski, JE, Ahram, M, Sloane, BF 2000Unraveling the role of proteases in cancerClin Chim Acta291113135CrossRefPubMed
92.
go back to reference McCarthy, K, Maguire, T, McGreal, G, et al. 1999High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancerInt J Cancer844448CrossRefPubMed McCarthy, K, Maguire, T, McGreal, G,  et al. 1999High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancerInt J Cancer844448CrossRefPubMed
93.
go back to reference Kanayama, H, Yokota, K, Kurokawa, Y, et al. 1998Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancerCancer8213591366CrossRefPubMed Kanayama, H, Yokota, K, Kurokawa, Y,  et al. 1998Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancerCancer8213591366CrossRefPubMed
94.
go back to reference Davidson, B, Goldberg, I, Kopolovic, J, et al. 1999MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma—a clinicopathologic study using immunohistochemistry and mRNA in situ hybridizationGynecol Oncol73372382CrossRefPubMed Davidson, B, Goldberg, I, Kopolovic, J,  et al. 1999MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma—a clinicopathologic study using immunohistochemistry and mRNA in situ hybridizationGynecol Oncol73372382CrossRefPubMed
95.
go back to reference Campo, E, Munoz, J, Miquel, R, et al. 1994Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survivalAm J Pathol145301309PubMed Campo, E, Munoz, J, Miquel, R,  et al. 1994Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survivalAm J Pathol145301309PubMed
96.
go back to reference Emmert-Buck, MR, Roth, MJ, Zhuang, Z, et al. 1994Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samplesAm J Pathol14512851290PubMed Emmert-Buck, MR, Roth, MJ, Zhuang, Z,  et al. 1994Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samplesAm J Pathol14512851290PubMed
97.
go back to reference Khan, A, Krishna, M, Baker, SP, Banner, BF 1998Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinomaMod Pathol11704708PubMed Khan, A, Krishna, M, Baker, SP, Banner, BF 1998Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinomaMod Pathol11704708PubMed
98.
go back to reference Khan, A, Krishna, M, Baker, SP, et al. 1998Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancerArch Pathol Lab Med122172177PubMed Khan, A, Krishna, M, Baker, SP,  et al. 1998Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancerArch Pathol Lab Med122172177PubMed
99.
go back to reference Murray, GI, Duncan, ME, O’Neil, P, et al. 1996Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancerNat Med2461462CrossRefPubMed Murray, GI, Duncan, ME, O’Neil, P,  et al. 1996Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancerNat Med2461462CrossRefPubMed
100.
go back to reference Kuniyasu, H, Ellis, LM, Evans, DB, et al. 1999Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinomaClin Cancer Res52533PubMed Kuniyasu, H, Ellis, LM, Evans, DB,  et al. 1999Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinomaClin Cancer Res52533PubMed
101.
go back to reference Sakakibara, M, Koizumi, S, Saikawa, Y, et al. 1999Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastomaCancer85231239CrossRefPubMed Sakakibara, M, Koizumi, S, Saikawa, Y,  et al. 1999Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastomaCancer85231239CrossRefPubMed
102.
go back to reference Tung, CH, Gerszten, RE, Jaffer, FA, Weissleder, R 2002A novel near-infrared fluorescence sensor for detection of thrombin activation in bloodChembiochem3207211CrossRefPubMed Tung, CH, Gerszten, RE, Jaffer, FA, Weissleder, R 2002A novel near-infrared fluorescence sensor for detection of thrombin activation in bloodChembiochem3207211CrossRefPubMed
103.
go back to reference Chen, J, Tung, CH, Mahmood, U, et al. 2002In vivo imaging of proteolytic activity in atherosclerosisCirculation10527662771CrossRefPubMed Chen, J, Tung, CH, Mahmood, U,  et al. 2002In vivo imaging of proteolytic activity in atherosclerosisCirculation10527662771CrossRefPubMed
Metadata
Title
MR and optical approaches to molecular imaging
Authors
T. Persigehl
W. Heindel
C. Bremer
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2005
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-004-0230-3

Other articles of this Issue 3/2005

Abdominal Radiology 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.